GEN Exclusives

More »

GEN News Highlights

More »
Oct 26, 2007

Scientists Discover Novel Mechanism for LDL in Heart Attacks

  • A team of Japanese researchers found that LDL may contribute to vascular diseases by a previously unidentified mechanism involving the activation of vascular endothelial growth factor receptor 1 (VEGFR1).

    Using cell lines and mouse models, the investigators discovered that when native LDL (nLDL) is bound to the LDL receptor, it can activate VEGFR1 and accelerate migration of macrophages, which accumulate in the plaques. Both these effects could contribute to the progression of plaques and blocking of arteries, report the authors.

    The research was conducted by scientists at Tokyo Women’s Medical University, the University of Tokyo, and Jichi Medical University. The study is published online October 26 in EMBO reports.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »